AAP
MBX

Arax Advisory Partners’s MBX Biosciences MBX Stock Holding History

Arax Advisory Partners’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.4K Buy
+279
New +$9.74K ﹤0.01% 4115
2025
Q4 		– Sell
-398
Closed -$6.96K – 4605
2025
Q3 		$6.96K Buy
+398
New +$5.32K ﹤0.01% 2750

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Arax Advisory Partners's MBX Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in MBX Biosciences (MBX) in Q2 2026: 279 shares worth $15.4K. The stake represents ﹤0.01% of the portfolio and ranks #4115 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in MBX as recently as Q3 2025.

Arax Advisory Partners first reported a position in MBX in Q3 2025 and has held it in 2 quarters since. 173 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • Arax Advisory Partners held 279 shares of MBX Biosciences worth $15.4K as of Q2 2026.
  • MBX Biosciences was a new Arax Advisory Partners position in Q2 2026.
  • MBX Biosciences made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4115 holding.
  • Arax Advisory Partners first reported a position in MBX Biosciences in Q3 2025 and has held it in 2 quarters since.
  • 173 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.